Stock 003020 HEFEI LIFEON PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hefei Lifeon Pharmaceutical Co., Ltd.

Equities

003020

CNE100004BD9

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
25.18 CNY +1.70% Intraday chart for Hefei Lifeon Pharmaceutical Co., Ltd. +7.33% -10.55%
May. 21 Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution MT
Apr. 29 Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Hefei Lifeon Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

3.QAvIeLS9TLgkqWY8-2P_NDPHoqA1l65sZyZ9aqWZJos.B2esNufPf5VD5SkPuDOPB2n-4Ndiw-FcU2osEtytbcVxbJ434IUGzXHeDQ~60c9d1e3502a3069839939825bcf48d1

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
25.18
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Ratings for Hefei Lifeon Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 003020 Stock
  4. Consensus Hefei Lifeon Pharmaceutical Co., Ltd.